10-K: Medicine Man Technologies, Inc. (Schwazze) Details Capital Structure and Regulatory Compliance in 10-K Filing

Sentiment:

Annual Results


Medicine Man Technologies, Inc., doing business as Schwazze, provides a detailed overview of its capital structure, regulatory compliance, and business operations in its recent 10-K filing.

Capital raiseThe company may seek to raise additional funds, finance acquisitions, or develop strategic relationships by issuing securities that would dilute the ownership of existing stockholders.The company has limited access to capital and funds available for operations and growth, and will require additional financing to successfully implement its business strategy.
Worse than expectedThe company's net loss increased from $18.47 million in 2022 to $34.55 million in 2023.The company's gross profit decreased by 5% in 2023 compared to 2022.The company's operating income decreased by 74% in 2023 compared to 2022.

Summary

  • Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated cannabis company with operations in Colorado and New Mexico.
  • The company is authorized to issue 250,000,000 shares of common stock and 10,000,000 shares of preferred stock.
  • Schwazze holds licenses from the Colorado Marijuana Enforcement Division and the New Mexico Cannabis Control Division.
  • The bylaws allow the company to redeem shares to prevent loss of licenses due to unsuitability of stockholders.
  • Holders of Series A Preferred Stock are entitled to cumulative dividends at 8% per annum and have liquidation preferences.
  • The company issued $95,000,000 of 13% senior secured convertible notes due in 2026.
  • The company operates 63 retail dispensaries, 6 cultivation facilities, and 3 manufacturing facilities as of March 1, 2024.
  • The company's common stock is listed on the OTCQX and the NEO Exchange under the ticker symbol SHWZ.
  • The company has completed several acquisitions to expand its market presence and achieve vertical integration.
  • The company's operations are organized into three segments: Retail, Wholesale, and Other.
  • The company uses METRC and BioTrackTHC for inventory tracking in Colorado and New Mexico, respectively.
  • The company employed 729 full-time and 111 part-time employees as of March 1, 2024.
  • The company is committed to environmental, social, and governance (ESG) principles.
  • The company's financial results were not materially impacted by the COVID-19 pandemic for the year ended December 31, 2023.
  • The Colorado cannabis market saw a 14% decrease in gross sales in 2023, while the New Mexico market grew by approximately 32%.
  • The company's CFO, Forrest Hoffmaster, was appointed interim CEO on February 23, 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company is expanding and has a strong retail presence, it also faces significant risks and challenges, including regulatory hurdles, intense competition, and financial losses. The sentiment is neutral to slightly negative due to the increased net loss and the need for additional financing.

Positives

  • The company has a strong retail presence with 63 dispensaries across Colorado and New Mexico.
  • The company has achieved vertical integration with cultivation and manufacturing facilities.
  • The company is expanding into new markets and has completed several acquisitions.
  • The company is committed to ESG principles and has a diverse workforce.
  • The company has a robust inventory tracking system in place.

Negatives

  • The company's bylaws allow for the redemption of shares to prevent loss of licenses due to unsuitability of stockholders.
  • The company has a significant amount of debt, including $95 million in convertible notes.
  • The company operates in a highly regulated industry with complex compliance requirements.
  • The company faces intense competition from other cannabis operators and the illicit market.
  • The company is subject to risks related to unsafe concentrations of heavy metals and other contaminants in its products.

Risks

  • The company's business is subject to federal laws that classify cannabis as a Schedule I controlled substance.
  • The company's operations are dependent on state laws pertaining to the cannabis industry, which are subject to change.
  • The company faces intense competition from other cannabis operators and the illicit market.
  • The company is subject to risks related to unsafe concentrations of heavy metals and other contaminants in its products.
  • The company's access to banking and other financial services is limited due to the federal illegality of cannabis.
  • The company may be unable to seek protection of the bankruptcy courts due to its involvement in the cannabis industry.
  • The company's stock price may be volatile due to its status as a relatively unknown company with a limited operating history.
  • The company may be forced to redeem shares of capital stock held by stockholders who are deemed unsuitable to be owners of the company.
  • The company's Preferred Stock ranks senior to its Common Stock but junior to all of its existing and future liabilities.
  • The company may be subject to cyber-attacks and non-compliance with applicable privacy laws.

Future Outlook

The company is focused on organic growth as well as growing through geographic expansion, acquisition, and application for new licenses in the Colorado and New Mexico cannabis markets, with the goal of expanding into new and emerging markets.

Management Comments

  • The company is focused on building a premier, vertically-integrated cannabis company by taking its retail operating playbook to other states where it can develop a differentiated leadership position.
  • The company blends purpose and a high-performance culture that employs customer-centric thinking and data science to test, measure, and drive decisions and outcomes.

Industry Context

The cannabis industry is expanding through the passage of legislation in many states permitting medical and/or recreational use of cannabis under state law. The Colorado market saw a decrease in sales in 2023, while the New Mexico market showed strong growth following legalization of adult-use cannabis sales.

Comparison to Industry Standards

  • The company competes with other multi-state operators (MSOs) such as Green Thumb Industries, iAnthus Capital Holdings, Acreage Holdings, and Curaleaf Holdings.
  • The company also competes with single-store operators, consumer packaged goods companies, cultivators, and illicit market participants.
  • The company's performance in Colorado is compared to competitors like Native Roots, Green Dragon, and LivWell.
  • The company's performance in New Mexico is compared to competitors like Pecos Valley, Oasis, and Dark Matter.
  • The company's financial performance is impacted by the cyclical nature of the agricultural industry and market conditions.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Interim Chief Executive OfficerNirup KrishnamurthyForrest HoffmasterFebruary 23, 2024Nirup Krishnamurthy's resignation as CEO and as a member of the Board of Directors.

Legal Proceedings

  • A Collective and Class Action lawsuit was filed against the Company, Schwazze New Mexico and R. Greenleaf, alleging violations of the Fair Labor Standards Act (FLSA) and the New Mexico Minimum Wage Act (NMMWA).
  • Mediation occurred on February 1, 2024, as a result of which the parties reached a preliminary settlement which must still be approved by the Court.

Related Party Transactions

  • The company has engaged in several transactions with entities owned or affiliated with its directors, including Justin Dye, Jeffrey Cozad, Marc Rubin, and others.
  • These transactions include the issuance of stock, convertible notes, and other financial arrangements.

Stakeholder Impact

  • Shareholders may experience dilution if the company raises additional capital through equity issuances.
  • Employees may be affected by changes in management and potential restructuring.
  • Customers may benefit from the company's expansion and increased product availability.
  • Suppliers may see increased business opportunities as the company grows.
  • Creditors may be impacted by the company's debt obligations and financial performance.

Next Steps

  • The company plans to continue expanding its operations in Colorado and New Mexico.
  • The company plans to explore new and emerging markets.
  • The company plans to continue to enhance its online presence via its house of brands website, and its investor relations website.

Key Dates

DateDescription
March 20, 2014Medicine Man Technologies, Inc. was incorporated in Nevada.
April 20, 2020The company rebranded to Schwazze.
December 16, 2020The company entered into a convertible promissory note and security agreement with Dye Capital.
December 7, 2021The company issued $95 million of 13% senior secured convertible notes.
February 8, 2022The company entered the New Mexico cannabis market with the acquisition of R. Greenleaf.
April 1, 2022Retail sales of adult-use cannabis products began in New Mexico.
June 1, 2023The company acquired 14 retail dispensaries, one cultivation facility, and one manufacturing facility from Everest.
February 23, 2024Forrest Hoffmaster was appointed interim CEO.
March 1, 2024The company owned and operated 63 retail dispensaries, 6 cultivation facilities, and 3 manufacturing facilities.

Keywords

cannabis, marijuana, dispensaries, cultivation, manufacturing, vertical integration, Colorado, New Mexico, OTCQX, NEO Exchange, SHWZ, licensing, regulations, convertible notes, acquisitions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.